What types of peptides does Thinheal supply?

Thinheal supplies generic peptide APIs, therapeutic peptides, GLP-1 analogues such as Semaglutide (CAS 910463-68-2), GLP-2 analogues, other gastrointestinal peptides, other therapeutic peptide APIs and cosmetic peptides for skin-care formulations.

Does Thinheal offer custom peptide development and CDMO services?

Yes. Thinheal provides project-based contract research and development, contract manufacturing and sales support, covering custom peptide development, process optimization, scale-up and commercial API supply through to formulation development.

What is Thinheal's production capacity?

Thinheal operates an R&D center and a production base in Hangzhou, China. Total production capacity for chemically synthesized peptides has reached the multi-ton level.

What documentation can buyers expect?

Each shipment is accompanied by batch analytical data such as a Certificate of Analysis. Additional documents required for supplier qualification or regulatory filings can be scoped with the sales and technical team for each project.

How do international buyers contact the right sales team?

Thinheal runs regional sales desks for USA & Europe, Russia & CIS & Europe, Asia, and the Middle East & East Asia. Buyers can also email info@thinheal.com or call +86 0571-86758863.

High-Quality Thymosin β4 acetate (TB500) CAS: 77591-33-4 Quotes, Pricelist

1 / 1

High-Quality Thymosin β4 acetate (TB500) CAS: 77591-33-4 Quotes, Pricelist

Thymosin β4 is a naturally occurring polypeptide (composed of 43 amino acids) widely expressed in the human body. It is an important member of the actin-binding protein family and was initially isolated from the thymus. Its core functions include promoting cell migration, proliferation, and differentiation; inhibiting inflammation and apoptosis; and promoting angiogenesis and wound healing. Based on these powerful biological functions, scientists have conducted extensive research on its therapeutic potential.

Send Inquiry

Product Description

Thymosin β4 (Tβ4) is a naturally occurring polypeptide composed of 43 amino acids, widely expressed in the human body. As an important member of the actin-binding protein family originally isolated from the thymus, its core biological functions include promoting cell migration, proliferation, and differentiation; inhibiting inflammation and apoptosis; and driving angiogenesis and wound healing. Extensive scientific research continues to explore its vast therapeutic potential.

Key Therapeutic Areas

Research on Thymosin β4 spans multiple therapeutic fields, ranging from advanced clinical trials to promising preclinical investigations:

1. Tissue Repair & Wound Healing

The most thoroughly researched field. Tβ4 accelerates repair via several mechanisms:

Cell Migration: Promotes movement of keratinocytes and endothelial cells to accelerate epithelialization.
Angiogenesis: Stimulates new blood vessel formation to supply oxygen and nutrients.
Anti-Inflammatory: Reduces inflammatory cell infiltration and enhances microenvironment.
Anti-Fibrotic: Regulates collagen production to minimize scar formation.

Specific Applications:

Skin Ulcers: Diabetic foot ulcers, pressure sores, and varicose ulcers (e.g., RGN-137 clinical trials).
Corneal Injury: Promotes epithelial regeneration for chemical burns, erosions, and dry eye syndrome.
Oral Mucositis: Speeds healing of chemo/radiotherapy side effects.

2. Cardiovascular Protection

Following a myocardial infarction (heart attack), Tβ4 exhibits protective and regenerative properties:

Cardiomyocyte Survival: Reduces cardiac cell apoptosis.
Vascularization: Enhances blood flow to the infarcted tissue area.
Stem Cell Recruitment: Mobilizes endogenous cardiac progenitor cells for myocardial regeneration.
Cardiac Function: Minimizes scar tissue to improve overall cardiac output.

Specific Applications:

Primary focus is acute myocardial infarction recovery and chronic heart failure treatment (e.g., early REGEN clinical trials).

3. Neurological Disorders

Leveraging neurotrophic and neuroprotective capabilities, Tβ4 presents potential in neuro-therapies:

Ischemic Stroke: Reduces infarct size, promotes neurogenesis/angiogenesis, and improves motor recovery.
Multiple Sclerosis: Exhibits strong anti-inflammatory and myelin regeneration-promoting effects.
Traumatic Brain & Spinal Injury: Protects neurological function through anti-apoptotic and neuroplasticity pathways.

4. Emerging Applications

Hair Regeneration: Activates hair follicle stem cells, shifting follicles from resting to active growth phase (anagen).
Anti-Aging Medicine: Acts as a regenerative molecule maintaining stem cell activity and counteracting age-related tissue decline.
Organ Fibrosis: Anti-fibrotic properties are actively investigated for treating liver cirrhosis and pulmonary fibrosis.

Outlook & Clinical Development

Opportunities & Strengths

Multi-Target Mechanism: Synergistically promotes tissue repair across multiple pathways simultaneously.
High Safety Profile: Natural endogenous protein, resulting in low immunogenicity.
Advanced Ophthalmic & Dermatological Progress: Eye drops and gels represent the closest products to full commercialization.
Regenerative Medicine Focus: Key molecule for stem cell activation and anti-aging research.

Challenges & Limitations

Clinical Inconsistency: Cardiac repair trials have shown mixed outcomes requiring broader validation.
Drug Delivery Obstacles: Peptide nature causes rapid oral degradation; targets require precise local or systemic delivery.
Regulatory & Financial Hurdles: High costs and strict regulatory endpoints slow translational progress.
Complex Molecular Pathways: Precise target signaling networks require deeper elucidation.

Current Clinical Status Summary

Stage: Most indications remain in preclinical or early-to-mid clinical phases.
Topical Formulations: Lead the way in development (e.g., gels for skin wound healing, eye drops for corneal repair such as RGN-137).
Systemic Delivery: Applications for heart disease and stroke progress slowly due to delivery complexities.
Industry Efforts: Specialized biotech firms continue to advance targeted clinical trials.

Conclusion

Thymosin β4 holds immense promise in regenerative medicine. Rather than a universal panacea, its immediate breakthrough lies in specific localized therapies, notably ophthalmic and dermatological wound repair.

Long-term success depends on proving consistent efficacy in large-scale clinical trials and refining peptide delivery technologies. It stands as a pivotal molecule in tissue regeneration research.

Frequently Asked Questions

What is Thymosin β4 (Tβ4)?

Thymosin β4 is a naturally occurring peptide composed of 43 amino acids. It plays a primary role in cell migration, tissue repair, anti-inflammatory responses, and new blood vessel formation.

What are the primary therapeutic uses of Thymosin β4?

The main therapeutic applications under research include skin wound healing, corneal repair, post-heart attack cardiac recovery, neuroprotective treatments for stroke, and hair regeneration.

How does Thymosin β4 promote wound healing?

Tβ4 works by accelerating the migration of skin and blood vessel cells to the injury site, stimulating angiogenesis (new blood vessel growth), reducing inflammation, and preventing excessive scar tissue formation.

Is Thymosin β4 effective for hair loss?

Preclinical studies show that Tβ4 can activate stem cells in hair follicles, prompting them to transition into the active growth phase. Research is ongoing for its development in topical hair regrowth formulations.

What are the biggest challenges in developing Thymosin β4 drugs?

Key challenges include delivering the peptide effectively to target organs without degradation, maintaining consistent clinical efficacy in large-scale human trials, and meeting strict regulatory standards.